TV News LIES

Wednesday, Oct 22nd

Last update05:18:43 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


US forces Ebola-risk passengers to land at 'enhanced screening' airports

Full screening airportThe United States has unveiled new Ebola-related travel restrictions on visitors from West Africa, forcing passengers...

Relief in Dallas as dozens declared Ebola-free after three weeks in isolation

dallas officialsDallas Ebola Dallas officials at a news conference. ‘I’m happy we can tell people they are...

Paralyzed man walks again after cell transplant

paralyzed man walks againA paralysed man has been able to walk again after a pioneering therapy that involved transplanting...

Nigeria Ebola outbreak declared over, but others in region still reeling

Nigeria Ebola freeThe World Health Organization (WHO) called Nigeria a “spectacular success story” Monday after it declared the...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!